Medtronic (MDT) Long-Term Investments (2014 - 2018)

Medtronic (MDT) has 5 years of Long-Term Investments data on file, last reported at $515.0 million in Q2 2018.

• For the quarter ending Q2 2018, Long-Term Investments fell 94.21% year-over-year to $515.0 million; the trailing twelve-month figure through Apr 2018 stood at $515.0 million (down 94.21% YoY), and the FY2018 full-year result was $515.0 million, down 94.21% from the prior year.
• Long-Term Investments declined to $515.0 million in Q2 2018, from $8.3 billion in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $15.2 billion in Q3 2015 to a low of $515.0 million in Q2 2018.
• A 5-year average of $10.3 billion and a median of $9.4 billion in 2016 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments grew 14.08% in 2015 and plunged 94.21% in 2018, its largest moves.
• Tracing MDT's Long-Term Investments over 5 years: stood at $13.0 billion in 2014, then rose by 15.85% to $15.1 billion in 2015, then slumped by 43.98% to $8.4 billion in 2016, then declined by 2.29% to $8.2 billion in 2017, then sank by 93.75% to $515.0 million in 2018.
• Business Quant data shows MDT's Long-Term Investments at $515.0 million in Q2 2018, $8.3 billion in Q1 2018, and $8.2 billion in Q4 2017.